𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies

✍ Scribed by G. Todeschini; C. Murari; R. Bonesi; G. Pizzolo; G. Amaddi; A. Ambrosetti; S. Cerù; I. Piacentini; N. Martini; P. Montresor; G. Perona

Publisher
Springer
Year
1993
Tongue
English
Weight
568 KB
Volume
12
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amphotericin B lipid complex versus lipo
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
✍ Ray Y. Hachem; Maha R. Boktour; Hend A. Hanna; Rola N. Husni; Harrys A. Torres; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematologic malignancy (HM). There are 2 lipid formulations of amphotericin B (AMB) currently in widespread use: AMB lipid complex (ABLC) and liposomal AMB (L‐AMB). There are limited

Liposomal amphotericin B in combination
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies : A randomized pilot study (Combistrat trial)
✍ Denis Caillot; Anne Thiébaut; Raoul Herbrecht; Stéphane de Botton; Arnaud Pigneu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a

Efficacy and toxicity of caspofungin in
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
✍ Dimitrios P. Kontoyiannis; Ray Hachem; Russell E. Lewis; Gustavo A. Rivero; Harr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Abstract ## BACKGROUND Caspofungin (CAS) as salvage therapy for refractory invasive aspergillosis (IA) had a response rate of 45% among a heterogeneous group of patients. The use of CAS with other agents is appealing given its unique mechanism of action. Therefore, the authors retrospectively e

Liposomal amphotericin B versus the comb
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction : Chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
✍ Gloria N. Mattiuzzi; Elihu Estey; Issam Raad; Francis Giles; Jorge Cortes; Yu Sh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Fungal infections are a major cause of morbidity and mortality in patients undergoing induction chemotherapy for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The authors evaluated the efficacy and toxicity of liposomal amphotericin B (L‐AmB) compar

Increased bone marrow iron stores is an
Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation
✍ Dimitrios P. Kontoyiannis; Georgios Chamilos; Russell E. Lewis; Sergio Giralt; J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a leading cause of death in patients with leukemia and those who have undergone hematopoietic stem cell transplantation. Laboratory studies have demonstrated that iron is essential for __Aspergillus__ growth and virulence. ## METHODS. In